Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1984 Jan;199(1):107–111. doi: 10.1097/00000658-198401000-00019

The influence of prophylactic antibiotics on the warfarin anticoagulation response in the postoperative prosthetic cardiac valve patient. Cefamandole versus vancomycin.

D M Angaran, V C Dias, K V Arom, W F Northrup, T E Kersten, W G Lindsay, D M Nicoloff
PMCID: PMC1353267  PMID: 6691723

Abstract

The influence of cefamandole and vancomycin used for prophylaxis on the warfarin anticoagulation response in 60 cardiac valve replacement patients during the postoperative period is presented. Patients were divided into two groups, hyper-responders prothrombin time (PT) greater than or equal to 32 sec, 48 hr after the initial warfarin dose (GrIHR), or normal responders PT less than 32 sec (GrIINR). Fifteen patients (25%) were in GrIHR (PT 44.3 +/- 10.5) and 45 in GrIINR (21 +/- 5). Fourteen of the 15 GrIHR patients received cefamandole and 1 of the 15 GrIHR patients received vancomycin p less than 0.05, as prophylaxis. Warfarin sensitivity was assessed using a warfarin dose index (WDI) calculated in the initial postoperative period (WDIINT) and at discharge (WDIDIS). GrIHR patients had greater WDIINT and WDIDIS compared to GrIINR p less than 0.001. Baseline prothrombin time measured 8 hours prior to start of warfarin therapy (PTBL), was linearly correlated to the WDIINT with r = 0.8, p less than 0.001 in cefamandole patients only. The data suggests that cefamandole increases warfarin sensitivity early in the postoperative course of oral anticoagulation therapy, which may lead to excessively high prothrombin times with the possibility for serious bleeding.

Full text

PDF
107

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barkhan P., Shearer M. J. Metabolism of vitamin K1 (phylloquinone) in man. Proc R Soc Med. 1977 Feb;70(2):93–96. [PMC free article] [PubMed] [Google Scholar]
  2. Bynum T. E., Boitnott J. K., Maddrey W. C. Ischemic hepatitis. Dig Dis Sci. 1979 Feb;24(2):129–135. doi: 10.1007/BF01324740. [DOI] [PubMed] [Google Scholar]
  3. Custer G. M., Briggs B. R., Smith R. E. Effect of cefamandole nafate on blood coagulation and platelet function. Antimicrob Agents Chemother. 1979 Dec;16(6):869–872. doi: 10.1128/aac.16.6.869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Frick P. G., Riedler G., Brögli H. Dose response and minimal daily requirement for vitamin K in man. J Appl Physiol. 1967 Sep;23(3):387–389. doi: 10.1152/jappl.1967.23.3.387. [DOI] [PubMed] [Google Scholar]
  5. Ham J. M. Hypoprothrombinaemia in patients undergoing prolonged intensive care. Med J Aust. 1971 Oct 2;2(14):716–718. doi: 10.5694/j.1326-5377.1971.tb92503.x. [DOI] [PubMed] [Google Scholar]
  6. Hooper C. A., Haney B. B., Stone H. H. Gastrointestinal bleeding due to vitamin K deficiency in patients on parenteral cefamandole. Lancet. 1980 Jan 5;1(8158):39–40. doi: 10.1016/s0140-6736(80)90571-1. [DOI] [PubMed] [Google Scholar]
  7. Kingsley D. P. Hepatic damage following profound hypothermia and extracorporeal circulation in man. Thorax. 1966 Jan;21(1):91–98. doi: 10.1136/thx.21.1.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lerner P. I., Lubin A. Letter: Coagulopathy with cefazolin in uremia. N Engl J Med. 1974 Jun 6;290(23):1324–1324. doi: 10.1056/NEJM197406062902317. [DOI] [PubMed] [Google Scholar]
  9. Nagashima R., O'Reilly R. A., Levy G. Kinetics of pharmacologic effects in man: the anticoagulant action of warfarin. Clin Pharmacol Ther. 1969 Jan-Feb;10(1):22–35. doi: 10.1002/cpt196910122. [DOI] [PubMed] [Google Scholar]
  10. Neu H. C. The new beta-lactamase-stable cephalosporins. Ann Intern Med. 1982 Sep;97(3):408–419. doi: 10.7326/0003-4819-97-3-408. [DOI] [PubMed] [Google Scholar]
  11. O'Reilly R. A., Aggeler P. M. Determinants of the response to oral anticoagulant drugs in man. Pharmacol Rev. 1970 Mar;22(1):35–96. [PubMed] [Google Scholar]
  12. O'Reilly R. A., Aggeler P. M. Studies on coumarin anticoagulant drugs. Initiation of warfarin therapy without a loading dose. Circulation. 1968 Jul;38(1):169–177. doi: 10.1161/01.cir.38.1.169. [DOI] [PubMed] [Google Scholar]
  13. Pineo G. F., Gallus A. S., Hirsh J. Unexpected vitamin K deficiency in hospitalized patients. Can Med Assoc J. 1973 Nov 3;109(9):880–883. [PMC free article] [PubMed] [Google Scholar]
  14. Reddy J., Bailey R. R. Vitamin K deficiency developing in patients with renal failure treated with cephalosporin antibiotics. N Z Med J. 1980 Nov 26;92(672):378–379. [PubMed] [Google Scholar]
  15. Routledge P. A., Chapman P. H., Davies D. M., Rawlins M. D. Pharmacokinetics and pharmacodynamics of warfarin at steady state. Br J Clin Pharmacol. 1979 Sep;8(3):243–247. doi: 10.1111/j.1365-2125.1979.tb01009.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Sellers E. M., Koch-Weser J. Kinetics and clinical importance of displacement of warfarin from albumin by acidic drugs. Ann N Y Acad Sci. 1971 Jul 6;179:213–225. doi: 10.1111/j.1749-6632.1971.tb46901.x. [DOI] [PubMed] [Google Scholar]
  17. Shepherd A. M., Hewick D. S., Moreland T. A., Stevenson I. H. Age as a determinant of sensitivity to warfarin. Br J Clin Pharmacol. 1977 Jun;4(3):315–320. doi: 10.1111/j.1365-2125.1977.tb00719.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES